Wilson Sonsini Goodrich & Rosati advised Pure Lithium on the transaction. Pure Lithium announced it secured $15 million in a Series A financing led by Oxy Low...
Pure Lithium’s $15 Million Series A Funding
Adela’s $48 Million Financing Round
Wilson Sonsini Goodrich & Rosati advised Adela on patent matters related to the transaction. Adela, Inc. announced the completion of a $48 million financing. The round included existing...
Delve Bio’s $35 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Delve Bio in the transaction. Delve Bio announced it has debuted with $35 million in Series A financing led by Perceptive...
Aspect Biosystems’ $2.7 Billion Collaboration with Novo Nordisk
Wilson Sonsini Goodrich & Rosati advised Aspect Biosystems on the transaction. Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, and leading global...
Metagenomi’s $100 Million Series B Extension Financing
Wilson Sonsini Goodrich & Rosati advised Novo Holdings and Metagenomi on the deal. Fenwick represented Metagenomi. Gene editing company Metagenomi announced a $100 million Series B...
Replay’s $55 Million Seed Funding
Wilson Sonsini advised Replay on the deal. Replay, a genome writing company reprogramming biology by writing and delivering big DNA, announced its launch with $55 million...
ReCode Therapeutics’ $120 Million Series B Financing
Wilson Sonsini Goodrich & Rosati represented ReCode Therapeutics in the transaction. ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of...
Mirvie’s $60 Million Series B Funding Round
Wilson Sonsini Goodrich & Rosati represented Mirvie on the deal. Mirvie, a pioneer in predicting unexpected pregnancy complications, announced it has raised $60 million in a...
Scipher Medicine’s $110 Million Financing Round
Wilson Sonsini advised Scipher Medicine on the deal. Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, announced the completion of...
Metagenomi’s $175 Million Series B Financing
Fenwick & West and Wilson Sonsini Goodrich & Rosati advised Metagenomi on the deal while Gunderson Dettmer represented PFM Health Sciences. Metagenomi, a genetic medicines company...
Metagenomi’s Collaboration with Moderna
Fenwick & West and Wilson Sonsini Goodrich & Rosati represented Metagenomi on the deal. Metagenomi, Inc., a genetic medicines company with a versatile portfolio of next-generation...
Aurora’s Merger With Reinvent Technology Partners Y
Wilson Sonsini Goodrich & Rosati, P.C. acted as legal counsel to Aurora, while Skadden, Arps, Slate, Meagher & Flom LLP advised Reinvent. Sullivan & Cromwell LLP...